Redefining MTM in the Post-health Reform Era

The healthcare industry has hit a crossroads that requires a strategic choice regarding the most effective allocation and use of clinical pharmacy resources on the path to performance improvement. As value-based care models drive the need for greater collaboration across clinical settings, the critical role of pharmacy expertise is heightened to accommodate a greater focus on ensuring medication effectiveness and minimizing potential for medication-related harm — a national crisis that has become the focal point of the risk-bearing regulatory landscape.

Download White Paper

You may also like:

Blog Post

As the U.S. Department of Health and Human Services (HHS) focuses its attention on drug pricing, a pharmacy advocacy group is urging HHS leadership not to ignore the issues presented by direct and indirect remuneration (DIR) fe...

View Blog Post
Blog Post

Patient engagement is defined differently by various clinicians, caregivers, health plans, and other providers. And healthcare organizations can have vastly divergent engagement goals. But one thing the majority of the healthca...

View Blog Post
Blog Post

A recent study sought to quantify the burden of opioid-related deaths in the United States and compare this burden over time and by age and sex.

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up